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Summary 
This paper examines the interplay between industrial and academic research and 
explores how innovation stimulated by the Royal Society has influenced technological 
development in business and industry over the past fifty years. The trend for 
universities to foster the creation of spin-out companies has grown significantly over 
the last twenty years, whilst universities and government simultaneously appreciated 
the potential value of intellectual property and increasingly formalised interaction 
between industry and academia. Prior to this the flow of ideas, discoveries and 
technology from universities to industry relied largely on individuals. Examples of 
how academics, industrialists and Fellows of the Royal Society have influenced and 
contributed to industrial research and the world’s technology base will be explored. 
The presentation will examine the supportive role played by the Royal Society 
through research grants, innovation awards, and distinguished Research Fellowships 
such as the Industry Fellowships Scheme. The most recent initiative to support 
scientific and technological ventures shows a new direction for the Royal Society in 
contributing to innovation through its Enterprise Fund. 
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Introduction 
One of the establishing features of the Royal Society was that it would be a force to 
benefit the British economy.  In this respect the role the Royal Society has to play in 
technological innovation in industry remains an important part of its portfolio.  
Technology innovation and its industrial application first became strongly evident during 
the industrial revolution of the 18th and 19th centuries when individuals such as Robert 
Stephenson, James Watt, Humphry Davy and Michael Faraday, all Fellows of the Royal 
Society, came to the fore and were celebrated for their contributions to both technology 
and the economy. The pace of scientific innovation and its acceptance by the public and 
business community increased during the 20th century. The appreciation that science 
makes important contributions to society became especially evident with major 
breakthroughs in medicine and health, such as Fleming’s discovery of penicillin to treat 
bacterial infections which drove the early growth of the pharmaceutical industry in the 
middle of the last century. Progressively the process of discovery and the monetary or 
strategic value that may be created has been recognised by businesses and 
governments.  This has led to a move away from associating invention and discovery 
purely with individuals and many important inventions and discoveries are now made 
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within a corporate environment in large research and development organisations, 
funded by major technology companies.   
 
The Role of Universities in Innovation and Industry 
Academia continues to have a very important role to play in both fundamental science 
and in the initial development of technological discoveries. The importance of this to 
both the institutions’ and the nation’s economy has been appreciated in recent years by 
both government and the universities themselves. Mowery and Rosenberg wrote in 
their text of 1989 that they believed in the benefits of greater industrial involvement in 
university research, which at the time was counter to the concerns present in both the 
USA and UK1. They commented on the effectiveness in the USA of universities 
contributing to industrial research, especially through the education of large numbers of 
engineers and scientists and contrasted this with British industrial research, which at the 
time they viewed as limited by low university enrolment. They also discussed the 
effectiveness of public policy toward technology. 
Collaboration in research and development between universities and industry started to 
increase after World War II when industry needed the resources and expertise of 
academic researchers to strengthen their product development capabilities. Arrow, in 
his much cited paper of 1959, discussed the funding of ‘invention’ by public bodies, 
including universities, and the interplay with the private sector from the perspective of 
the economic value and impact of invention2. Over the past twenty five years the 
recognition and engagement of universities with the innovation, knowledge transfer and 
technology transfer process has increased dramatically. Up to 1980 the exploitation of 
innovation in universities had in general been very much left to individual scientists and 
engineers and their own entrepreneurial interests, with the possible exception of the 
recognition of the value of drug discovery, which some universities already benefited 
from financially. Examples of companies that were formed by entrepreneurial 
academics, but without the support of their universities, include Oxford Instruments in 
1959 and Filtronic in 1977. Oxford Instruments was founded by Martin and Audrey 
Wood with an academic base in Oxford’s Physics Department. Filtronic was founded by 
David Rhodes, exploiting his microwave filter research interests that he had established 
in the Department of Electronic and Electrical Engineering at Leeds.   
After this time, interest in commercial exploitation of research by UK universities led to 
the formation of spin-out companies and the recognition of benefits from licensing of 
intellectual property. Richards3 describes the growth of the spin-out culture at Oxford 
during the last twenty years and process and funding routes that facilitate the growth of 
successful companies from research and intellectual property created in universities. 
 
1 D.C. Mowery, N. Rosenberg, Technology and the Pursuit of Economic Growth, (Cambridge University 
Press, New York, 1989) 
2 2    K.J. Arrow, Economic Welfare and the Allocation of Resources for Invention, P-1856-RC, pp1-23 
(The RAND Corporation, Santa Monica California, December 1959). 
3 G. Richards, Spin- Outs: Creating Business from University Intellectual Property, First Edition 
(Harriman House, Petersfield, 2009)  
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The rise of interest in universities engaging technology enterprise activities probably has its 
roots in the United States in the middle of the last century. Stanford, MIT and Harvard 
strongly influenced the emergence of high technology companies in California and 
Massachusetts, often benefiting from funding available from the US government’s defence 
department (DoD). Later a similar combination of intellectual capability and DoD funding, 
often through the Small Business Innovation Research programme established in 1982, led 
to the rapid growth of other research clusters, such as in the Research Triangle of North 
Carolina. The Bay-Dole Act in 1980, allowed universities to patent federally funded research 
and exploit this intellectual property.  This lead to a ten fold increase in patent generation 
with an associated rapid growth in licensing and spin-out activity.   
The UK has generally had a more risk-averse approach to funding innovation and 
although the National Research Development Corporation was established in 1948 to 
commercialise inventions created using publicly funded research, the UK did not see any 
significant growth in academic-enterprise until the early 1980s. This coincided with a 
change in taxation policy in the UK, which encouraged venture capital funding, often 
necessary to fund new technology companies. In 1987, universities were formally 
recognised as owning intellectual property developed using government funding and 
were encouraged to engage more strongly in knowledge transfer. Since that time, 
knowledge transfer and enterprise activities, often based around technology, have 
grown dramatically and in 2008 the Higher Education Funding Council of England 
reported that UK higher education institutions generated £1.3 Bn knowledge transfer, 
growing at a rate of 20% whilst generating 220 spin-out companies in that year4. In 
2007/8 university spin-outs employed close to 14,000 staff with a turnover of £1.1 Bn 4. 
The Royal Society’s report ‘The Scientific Century: securing our future prosperity’, 
recognises that over the last fifteen years, UK universities have responded vigorously to 
the challenge of increasing knowledge transfer into industry5. It also recognises that the 
support and incentives our universities receive play key roles in encouraging translation, 
commercialisation and knowledge exchange. 
Throughout the period 1950-1990 universities in North America and UK formed research 
parks which provide a close connection between academic innovation in universities 
and businesses – especially those with strong entrepreneurial leadership such as start-
ups and spin-outs.  Examples of especially successful research parks and technology 
clusters in the USA and UK include Stanford Research Park, University Park at MIT, 
Research Triangle Park (North Carolina),  Surrey Research Park; Cambridge, Manchester, 
Oxford, Southampton and Warwick Science Parks; Peel Park (East Kilbride) and Adastral 
Park Ipswich. Royal Society Fellows have had a major part to play in these parks 
including the one at Surrey which was established by Anthony Kelly FRS in the early 
1980s. Professor Lord Rees, President of the Royal Society presided over the official 
opening of new facilities at Chesterford Research Park in 2009. Research parks are now 
widely used globally to help concentrate and support technology companies. 
 
4 Higher Education - Business and Community Interaction, Reference 2008/2, HEFCE, 2008. 
Surveyhttp://www.hefce.ac.uk/pubs/hefce/2008/08_22/ also  
http://www.hefce.ac.uk/news/hefce/2008/hebci.htm 
5 The Scientific Century:  securing our future prosperity, The Royal Society (March 2010) 
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The last ten years have seen increased investment in research and support for 
innovation in the UK public sector and this has stimulated considerable activity between 
universities, industry and business. In the nine years to 2008, the number of patents 
granted to universities rose by 136% and consultancy income rose 222%. The 
establishment of the Technology Strategy Board (TSB), initially as an advisory board to 
government departments in 2004 and subsequently as an independent body (‘arm’s 
length’ from government) in July 2007, has had a significant impact on accelerating 
innovation and creating value in technology companies. The TSB supports the 
Knowledge Transfer Partnerships, which have proven extremely effective in linking 
university research and support to small to medium size enterprises (SMEs); Knowledge 
Transfer Networks for a number of science, engineering and technology based sectors. 
Innovation Platforms have been implemented, which are programmes intended to 
stimulate innovative solutions within UK businesses.   
Often many innovations and the route to exploitation require multi-disciplinary expertise. 
Universities present an ideal environment in which to nucleate multi- and inter-disciplinary 
research and innovation. The rise in multi-disciplinary research led the Royal Society to 
introduce its successful ‘Interface’, the first new journal for over 150 years, as a 
collaborative venture developed in conjunction with the Engineering and Physical Sciences 
Research Council. This has been instrumental in supporting cross-disciplinary relationships 
between engineering and physical sciences and life sciences in the UK. In less than three 
years, ‘Interface’ became the fourth most highly-cited interdisciplinary journal in the world, 
behind ‘Science’, ‘Nature’ and the Proceedings of the National Academy of Sciences. It was 
developed in response to pressure from scientists who were finding few places to publish 
inter-disciplinary work that bridges the physical and life sciences, such as the mathematical 
modelling of infectious diseases, or the engineering of new organisms. ‘Interface’ is ideal for 
supporting the dissemination of discoveries in the area of synthetic biology where the 
investigators are drawn from disciplines as diverse as engineering, biology and computer 
science. The Royal Society is now planning a cross-disciplinary journal which will be called 
‘Interface Focus’ with publication on-line and in printed form. 
 
Supporting Researchers and Innovators 
Support for individuals engaged in innovation has relied historically on research council 
funding or the support of wealthy benefactors.  In the early stages of innovation, typically 
beyond the basic research stage, it used to be difficult to secure funding to allow individuals 
to develop their ideas to the point where it could be the basis of a product, company or 
license arrangement. This stage of innovation work used to fall outside the remit of research 
councils and prior to the formation of organisations such as the Technology Strategy Board 
and seed funding within universities, many individuals would fail to win the support they 
needed to take their ideas through to a commercial phase when venture capital, private 
equity or other sources of funds then become accessible. 
The Royal Society’s Brian Mercer Awards for Innovation were established in 2001 to   
provide meaningful funding for individuals or groups to develop an already proven concept 
or prototype through to the creation of a near-market product for commercial exploitation. 
This is intended to help facilitate the inventors to take the project to the point where the 
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prospect of venture capital becomes a reality. Dr Mercer was an enthusiastic inventor and 
entrepreneur and these awards aim to encourage these qualities in the next generation of 
scientists.  Early stage ideas and concepts can be funded from the Brian Mercer Feasibility 
Awards scheme, which provides initial support to test the feasibility of a project. This 
enables holders to investigate the technical and economical feasibility of commercialising an 
aspect of their scientific research, possibly in conjunction with a third party and to such a 
point where an industrial or commercial collaboration can be established. These awards are 
focused in areas of built environment, clean technology, energy, nanoscience and 
nanotechnology.   
 
Case Study 
Support from the Royal Society played a fundamental roll in technological innovation and 
successful exploitation of a new osmosis process that led to the rapid and successful 
floatation of a company on AIM in 2008. Professor Adel Sharif, Director of the Centre for 
Osmosis Research and Applications (CORA) at the University of Surrey, was awarded The 
Royal Society’s Brian Mercer Senior Award for Innovations in Science and Technology in 
2005. The Centre’s research activities in the area of osmosis science have resulted in a 
number of inventions in the areas of desalination, water treatment, and renewable energy. 
These discoveries have the capacity to significantly change the economic and performance 
characteristics of industries such as desalination, water treatment, power generation, oil, 
chemical and energy industries that use or produce large quantities of dilute solutions. 
Desalination has the potential to create secure water supplies for many countries around 
the world. The £250k Brian Mercer Award helped fund the development of a new 
manipulated osmosis technology for seawater desalination. 
The University of Surrey established Surrey Aquatechnology Ltd in 2005, using its own seed 
fund, with Professor Sharif as the founding director, to commercialise the IP and research 
outputs of CORA, especially the work that had been supported by the Mercer Award earlier 
that year.  Surrey Aquatechnology was subsequently merged with Modern Water and the 
new entity was floated on the London AIM market in June 2007 creating an initial market 
value of £70m. http://www.royalsoc.ac.uk/news.asp?id=6757 Sharif’s core technology of a 
manipulated osmosis desalination process converts seawater to drinking water, using a 
selectively permeable membrane. It achieves this with a significant reduction in capital and 
operating costs as it reduces energy use by the desalination plant and lowers the 
consumption and disposal of hazardous chemicals. Modern Water has subsequently built a 
desalination plant in Gibraltar, the first in the world to use manipulated osmosis, that 
produced its first fresh water in September 2008 and they supplied a further manipulated 
osmosis plant to Oman in 2009. The company maintains a research collaboration with the 
university that has produced a further six desalination-related patents. Professor Sharif and 
Modern Water were the winners of the Energy/Environmental award of the pan-European 
Enterprise ACES Award at the Royal Academy of Engineering in Stockholm on 2nd December 
2008 for their innovative development of water purification desalination technologies. 
Recent winners of Brian Mercer Awards include nanotechnology innovators Dr Andrea 
Ferrari from the University of Cambridge (2007) to develop polymer based ultrafast pulse 
lasers for applications such as data transmission, micromachining and medical diagnostics; 
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Dr Andrew Nelson from the University of Leeds (2008) for developing a device to detect 
toxicity of nanoparticles (such as those in toothpaste and sun screen lotions) in the water 
system; built-environment innovators Professor David Stuckey from Imperial College (2007) 
who is developing a revolutionary waste water recycling technology; and Professor Kirill 
Horoshenkov (2008) with a novel acoustic technique for assessing sewer pipes. 
 
Industry Fellowships 
The Royal Society supports over 600 research appointments through its various 
schemes. The Society’s Industry Fellowships Scheme, which is funded by the Royal 
Society and the UK’s Engineering and Physical Sciences Research Council, the 
Biotechnology and Biological Sciences Research Council, the Natural Environment 
Research Council, Rolls Royce plc and Astra Zeneca aims to enhance knowledge transfer 
in science and technology between industry and academia by supporting researchers for 
up to two years. This scheme allows academic scientists to work on collaborative 
projects with industry or alternatively for a scientist or engineer in industry to work on a 
collaborative project with a research group in a university or not-for-profit organisation. 
It is hoped that this will foster long term relationships and corporate links. The scheme 
encourages work with spin-out companies and small-medium enterprises. The Society’s 
Leverhulme Trust Senior Research Fellowships support shorter research periods, but 
includes both universities and industrial research organisations. 
Although not aimed at industrial collaboration, the Royal Society’s Dorothy Hodgkin 
Fellowships are available to provide support to scientists and engineers at an early stage 
of their career, and are designed to help them to progress to a permanent position. 
They are aimed specifically at researchers who require a flexible working pattern due to 
personal circumstances including parental, caring responsibilities and health issues.  In 
some cases they can provide a bridge between academic research and real-world 
application. This may take the form of a traditional link with a technology company 
(possibly through sponsorship) or more recently some Dorothy Hodgkin Fellows have 
participated in the Member of Parliament-Scientist pairing scheme which facilitates a 
different route to dissemination and public understanding, linking areas such as science 
and health with politics. 
 
Royal Society Fellows and their Role in Industry, Enterprise and Technology Transfer 
Many technology companies have benefited from the contributions of Fellows and in 
many cases they were founding members of these companies.  Amongst the many 
Fellows of the Royal Society who have founded or played major roles in the growth of 
technology companies are David Payne, co-inventor of the erbium doped fibre amplifier, 
founder York Technologies (now PK Technology inc) and SPI lasers; David Rhodes, who 
founded Filtronic based on his award winning filter technologies; Sir Richard Friend 
world renowned for his research on carbon-based semiconductors and founder of 
Cambridge Display technology and Plastic Logic;  Steve Furber, designer of 
microcomputers and principal designer at Acorn and ARM; Peter Lawrenson, founder of 
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Switched Reluctance Drives (SRD); Sir Martin Sweeting, founder of Surrey Satellite 
Technology which led to the largest ever cash-spin out of a company from a university. 
Other visionary scientists have contributed to innovations that have fundamentally 
changed the way that scientifically-driven industries operate. Such an example is Sir 
John Sulston, who saw the building and establishment of the Wellcome Trust Sanger 
Institute between 1993 and 1994 and subsequently participated in the mapping, 
sequencing and analysis of genomes and contributed a major part to the Human 
Genome Project. What had seemed impossible in the early 1990s had been achieved by 
Sulston and colleagues within ten years and is playing a key role in transforming 
diagnosis, prevention and treatment of many common diseases6,7.  
Another example of the role that Fellows have played in revolutionising a technology 
industry and its application is found in the work of César Milstein (with the then post-
doctoral assistant Georges Köhler) and Sir Gregory Winter. Milstein and Köhler received 
the Nobel Prize in 1984 for their 1975 work on monoclonal antibodies. Sir Gregory’s 
work with Milstein in 1986 at Cambridge’s MRC Laboratory, through the application of 
genetic engineering, led to the development of monoclonal antibodies for therapeutic 
drugs. Winter’s further work enabled the generation of human antibodies in bacteria, 
bypassing the need to immunize humans. Monoclonal antibodies now account for a 
third of all new pharmaceutical treatments and generate over US$ 32 Bn in market 
terms8. Royalties from Winter’s work have generated over £300m for the MRC in 
royalties from licenses issued to 50 companies. Winter went on to found Cambridge 
Antibody Technology, with colleague David Chiswell, which was acquired by Astra 
Zeneca in 2006 for £702m. In the same year, GlaxoSmithKline acquired Domantis for 
£230m, which had also been founded by Winter with Ian Tomlinson. These dramatic 
examples show how science and technology, coupled to support from national research 
councils can generate breakthroughs of immense value to society as well as creating 
enormous economic benefits. 
There are also examples of Fellows whose research led to innovation and exploitation 
where the Fellow involved decided to support the work of The Royal Society. Sir Edward 
P. Abraham was a distinguished biochemist, who worked on the development of 
Penicillin (working with Howard Florey) and later cephalosporin, an antibiotic used to 
combat penicillin-resistant bacteria in pneumonia septicaemia and bronchitis. His patent 
on cephalosporin generated a substantial income and Abraham used these funds to 
generate two charitable trusts. The Royal Society and its work were generously 
supported by these trusts for many years. 
 
 
 
6 House of Lords Science and Technology Committee (2009). Genomic Medicine. The Stationery Office: 
(London, 2009) 
7 Academy of Medical Sciences (2010). Reaping the Rewards: a vision for UK medical science. Academy 
of Medical Sciences (London, 2010). 
8 BBSRC (2009) Science making and economic difference. www.bbsrc.ac.uk/science/impact/economic-
impacts.aspx. 
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Supporting a Culture of Innovation 
The Royal Society has for many centuries engaged with government, universities and 
industry to promote science, and innovation. In 2006, the ‘UK Mind to Market’ delegation 
was put together to showcase the UK’s science innovation-industry sector at the India ‘R&D 
2006: Mind to Market’ conference, and to allow for the exchange of information and the 
exploration of opportunities for UK-India collaboration in promoting innovation and wealth 
creation through science. The visit was organised by the Royal Society and supported by UK 
Trade & Investment (UKTI) and the UK Office of Science and Innovation (OSI) under the 
Indo-UK Science Networking Programme. The conference and networking meetings were 
hosted by the Federation of Indian Chambers of Commerce and Industry (FICCI), the Indian 
National Science & Technology Entrepreneurship Development Board (NSTEDB) and the 
British High Commission in India. The subsequent report summarised the key issues and 
challenges that emerged from the networking visit. 
More recently and topically, The Royal Society hosted the Innovation Summit in December 
2009, organised by leading universities and technology companies to explore the way that 
innovation can lead the economy out of recession. It addressed the controversial issue of 
whether universities that focus on protecting intellectual property are helping or hindering 
the innovation process. 
 
Funding for Innovation and Enterprise 
The role of venture capital and private equity in funding start-up businesses and spin-outs 
has become well established over the past twenty five years. The Royal Society Enterprise 
Fund has been created to make equity investments in innovative early-stage businesses 
emerging from the science base in the UK and elsewhere. The Fund leverages the Royal 
Society's technical and scientific network, the extensive science policy work and the flexible 
time horizons for investment. The focus is on early-stage investment opportunities and the 
Fund is run on a commercial basis. In order to ensure long-term sustainability, the Fund is 
financed from donations to the 350th Anniversary Campaign. The Fund is intended to be 
evergreen, with financial gains recycled for reinvestment in future innovative technology-
based opportunities. The operation of the Fund complements the many other activities 
supported by the Royal Society and designed to encourage the exploitation of science for 
societal benefit. Investments are made in start-up companies who can demonstrate they 
have outstanding scientific innovation and which have real commercial potential. The Royal 
Society's networks and relationships are used to highlight and then calibrate investment 
opportunities.  The Fund has a goal to raise £20 million and aims to attract external 
investment activity into early-stage companies and to generate long-term financial returns, 
which are recycled back into the Fund. It is intended to serve as a model for the successful 
commercial application of the results of outstanding research. 
The Enterprise Fund made its first investment in August 2009 in the company Novacem 
which is developing a new generation of carbon negative cement systems. The technology is 
based on research from Imperial College London. The annual production of traditional 
Portland cement is over 2.5 billion tonnes and is responsible for 5% of global carbon dioxide 
emissions with cement production expected to double by 2050. In contrast to Portland 
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cement, Novacem’s cement absorbs more carbon dioxide than it emits over its life cycle. 
Widespread adoption of this revolutionary new material has the potential to transform the 
cement industry from a significant emitter to a significant absorber of carbon dioxide. 
 
Future Directions 
The Royal Society’s major policy study, ‘The Scientific Century: securing our future 
prosperity’ 5, which included the work on The Fruits of Curiosity, has been reviewing the 
landscape for UK science and innovation policy and exploring its direction over the next ten 
to twenty years. The study measures the different forms of value created by science, 
engineering and medicine for the UK’s economy and society and will consider the role that 
science will play in equipping Britain to meet future economic, social and environmental 
challenges. It is clear that universities play an important role in technology innovation and 
that the Royal Society and its Fellows have a key role to play in generating future ideas, 
research and subsequently creating benefits for society and the economy. 
 
